INMD:NASDAQ, InMode Ltd.
INMD stock overview
InMode Ltd. (INMD:NASDAQ) closed at $13.97 on October 23, 2026,
down 0.57% on the day.
The stock trades 16.2% below its 52-week high of $16.67
and 9.8% above its 52-week low of $12.72.
Over the past year, it lost 8.8%.
InMode Ltd. is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
Key figures
- Price
- $13.97
- Day change
- -0.57%
- Volume
- 420,688
- Average volume
- 478,370
- Market cap
- 803M+
- 52-week range
- $12.72 – $16.67
- 50-day average
- $14.55
- 200-day average
- $14.36
Price action over the past year
In 252 trading sessions since October 23, 2025, INMD closed higher on 112 days (44%).
Its best day was June 24, 2026 (+10.79%) and its worst was January 8, 2026 (-8.82%).
The stock moved 10% or more in a single session 2 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
INMD news
-
Oct 19, 2026:
Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer
-
Oct 13, 2026:
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
-
Sep 9, 2026:
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
-
Sep 1, 2026:
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
-
Aug 5, 2026:
InMode: Q2 Earnings Snapshot
-
Aug 5, 2026:
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
-
Jul 28, 2026:
Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting
About InMode Ltd.
InMode Ltd is a provider of minimally-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions are designed to address three energy-based treatment categories including face and body contouring, medical aesthetics and women's health. The technologies offered by the company include BodyTite, Contoura, EmbraceRF, Optimas, and Votiva among others.
Similar stocks
Find more stocks like INMD with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.